To better predict the likelihood of Alzheimer's
(combination of medical tests)
(combination of medical tests)
Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it.
DONATE NOW\
According to scientists from the University of California, San Diego School of Medicine, a combination of broadly available medical tests can yield a superior predictive picture of the likelihood of impending Alzheimer's disease in patients with mild cognitive impairments. This is an intermediate stage between the expected cognitive decline of normal aging and the more pronounced decline of dementia.
"This is good news for individuals who score a negative on these tests because they have no greater risk of near-term dementia than a similarly aged healthy person without a memory complaint," Slome notes.
To determine the likelihood of developing Alzheimer's According to scientists from the University of California, San Diego School of Medicine, a combination of broadly available medical tests can yield a superior predictive picture of the likelihood of impending Alzheimer's disease in patients with mild cognitive impairments. This is an intermediate stage between the expected cognitive decline of normal aging and the more pronounced decline of dementia.
"This is good news for individuals who score a negative on these tests because they have no greater risk of near-term dementia than a similarly aged healthy person without a memory complaint," Slome notes.
To determine the likelihood of developing Alzheimer's disease, researchers compared risk factors based on magnetic resonance imaging along with neuropsychological tests widely available to clinicians. They found that using available biomarkers significantly improved accuracy in predicting near-term conversion to dementia.
Financial planning experts advise that adults in their 50s and young 60s with a family history of cognitive disorders including Alzheimer's look into long term care insurance. "Insurance is only available to those who can medically qualify," Slome explains, "because the long term care insurance industry already pays out over $6 billion a year in claims, so they look for those who aren't already diagnosed with some risky condition." disease, researchers compared risk factors based on magnetic resonance imaging along with neuropsychological tests widely available to clinicians. They found that using available biomarkers significantly improved accuracy in predicting near-term conversion to dementia.
Financial planning experts advise that adults in their 50s and young 60s with a family history of cognitive disorders including Alzheimer's look into long term care insurance. "Insurance is only available to those who can medically qualify," Slome explains, "because the long term care insurance industry already pays out over $6 billion a year in claims, so they look for those who aren't already diagnosed with some risky condition." Continue to read: newsblaze.com
B-vitamins may slow cognitive decline
Daily supplements of B vitamins may slow the decline in mental function in people with mild cognitive impairment, says a new clinical trial. Read more: nutraingredients-usa.com